New hope for kids with tough leukemia: Gene-Edited transplant trial opens
NCT ID NCT07257419
First seen Jan 05, 2026 · Last updated Apr 29, 2026 · Updated 20 times
Summary
This study tests a new way to do stem cell transplants for children with a high-risk type of leukemia (CD19+ ALL) that has come back or not responded to treatment. Doctors will use a special type of donor cells (from a partially matched family member) and then give the child an extra dose of immune cells (CD19-CAR T cells) to try to kill any remaining cancer. The main goal is to see if this combination is safe and possible for up to 60 children.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
St. Jude Children's Research Hospital
RECRUITINGMemphis, Tennessee, 38105, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.